Introduction
Glaucoma is the most common cause of irreversible blindness and will affect more than 100 37 million individuals between 40 to 80 years of age by 2040(1). Annual direct medical costs to 38 treat this disease in 2 million patients in the United States totaled $2.9 billion(2). Glaucoma is a 39 neurodegenerative disease characterized by optic neuropathy with thinning of the retinal nerve 40 fiber layer (RNFL) followed by progressive retinal ganglion cell (RGC) degeneration (3) (4) (5) (6) (7) (8) (9) (10) (11) . 41 Elevated intraocular pressure (IOP) is the most common risk factor(12). Current therapies target 42 reduction of IOP, but irreversible RGC death continues even after IOP is normalized (13) (14) (15) , 43 indicating the critical clinical need to prevent degeneration of glaucomatous RGCs and optic 44 nerve (ON). Similar to other chronic neurodegenerative diseases(16), the search for 45 neuroprotectants to treat glaucoma is ongoing. To longitudinally assess the molecular 46 mechanisms of glaucomatous degeneration and the efficacy of neuroprotectants, a reliable, 47 reproducible, and inducible experimental ocular hypertension/glaucoma model is critically 48 important. 49 50 The rodent has been adopted as the mammalian experimental species of choice for 51 modeling human diseases and large-scale genetic manipulations. Various rodent ocular 52 hypertension models have been developed including spontaneous mutant or transgenic mice and 53 rats and mice with inducible blockage of aqueous humor outflow from the trabecular meshwork 54 (TM) (17) (18) (19) (20) . While genetic mouse models are valuable to understand the roles of a specific gene 55 in IOP elevation and/or glaucomatous neurodegeneration, the pathologic effects may take 56 months to years to manifest. Inducible ocular hypertension that develops more quickly and is 57 more severe term would be preferable for experimental manipulation and general mechanism 58 studies, especially for neuroprotectant screening. Injection of hypertonic saline and laser 59 photocoagulation of the episcleral veins and TM are commonly used in rats and larger 60 animals(18). Although similar techniques also produce ocular hypertension in mice(21-23), they 61 are technically challenging, and irreversible ocular tissue damage and intraocular inflammation 62 complicate their interpretation (17, 20) . Intracameral injection of microbeads to occlude aqueous 63 humor circulation through TM produces excellent IOP elevation and glaucomatous 64 neurodegeneration (24) (25) (26) (27) . However, the difficulty of retaining microbeads at the angle of 65 anterior chamber and of controlling the degree of aqueous outflow blockade results in a low 66 success rate and high variabilities in the magnitude of IOP elevation and neurodegeneration. 67 Furthermore, its lengthy duration (6-12 weeks after microbeads injection) causes death of only 68 30% of RGC(26, 28, 29) , leaving a narrow window for preclinical testing of neuroprotective 69 therapies. It is therefore critically important to develop a simple but effective ocular hypertension 70 model in mice that closely resembles human glaucoma, and that can be readily adapted to larger 71 animals with minimal confounding factors. 72 73 A well-documented, secondary glaucoma with acutely elevated IOP occurs as a post-74 operative complication following the intravitreal use of silicone oil (SO) in human vitreoretinal 75 surgery (30, 31) . SO is used as a tamponade in retinal detachment repair due to it being buoyant 76 with high surface tension. However, SO is lighter than the aqueous and vitreous fluids and an 77 excess can physically occlude the pupil, which in turn prevents aqueous flow into the anterior 78 chamber. This obstruction leads to increased aqueous pressure in the posterior chamber and 79 anterior displacement of the iris, which causes angle-closure, blockage of aqueous outflow 80 through TM, and a further increase in IOP. Based on this clinical experience, we tested a simple 81 procedure for intracameral injection of SO to block the pupil and cause ocular hypertension, 82 which faithfully replicates post-operative secondary glaucoma. 83 84 Endoplasmic reticulum (ER) stress is a complex cascade of reactions that are activated 85 when the ER, the organelle responsible for synthesis and proper folding of proteins, is 86 overwhelmed by unfolded and misfolded proteins, a process that is called the unfolded protein 87 response (UPR) (32, 33) . We previously identified the important role of ER stress in 88 glaucomatous neurodegeneration and demonstrated significant neuroprotection of RGC and ON 89 by modulating ER stress molecules, C/EBP homologous protein (CHOP) and X-box binding 90 protein 1 (XBP-1) (29, 34, 35) . Here we apply an adeno-associated virus (AAV) that mediates 91 CHOP inhibition and XBP-1 activation in a single vector to the SO-induced ocular hypertension 92 model. We report that this treatment increases RGC somata and axon survival and significantly 93 improves recovery of visual function, which validates these two ER stress molecules as 94 therapeutic targets for glaucoma neuroprotection. This proof-of-concept study demonstrates this 95 model to be an effective way to test neuroprotective strategies in vivo, which can be adapted 96 more broadly to larger pre-clinical animals.
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Results
99
Intracameral SO injection induces ocular hypertension by blocking the pupil and aqueous 100 humor drainage in the mouse eyes 101 Although intravitreal injection of SO in vitreoretinal surgeries can cause post-operative 102 secondary glaucoma in humans(30, 31), we reasoned that direct injection of SO into the anterior 103 chamber of mice would be more efficient, preventing the need to remove the vitreous and 104 reducing toxicity due to direct contact with the retina. As illustrated in Fig. 1A,B and Movie S1, 105 after intracameral injection SO forms a droplet in the anterior chamber that contacts the surface 106 of the iris and tightly seals the pupil due to high surface tension. To test whether SO blocks 107 migration of liquid from the back of the eye to the anterior chamber, we injected dye (DiI) into 108 the posterior chamber and visualized its migration into the anterior chamber. In dramatic contrast 109 to a normal naïve eye, in which copious dye passed through the pupil and appeared in the 110 anterior chamber almost immediately after injection, no injected dye reached the anterior 111 chamber of the SO eye (Movie S2,S3). This result indicates that SO causes effective pupillary 112 block. 113 The ciliary body constantly produces aqueous humor, which accumulates in the posterior 114 chamber and pushes the iris forward. When the iris root touches the posterior corneal surface, the 115 anterior chamber angle closes ( Fig. 1A) , as evidenced by live anterior chamber optical coherence 116 tomography (OCT) (Fig. 1B) . The angle closure can further impede the outflow of aqueous 117 humor through TM and also contributes to IOP elevation. Dilation of the pupil until it is larger 118 than the SO droplet can relieve the pupillary block. Movie S4 shows that after pupil dilation 119 aqueous humor floods into the anterior chamber and pushes the SO droplet away from the iris, 120 which reopens the anterior chamber angle (Fig. 1A,B ). Together, these results characterize the We measured the IOP of the experimental eyes after a single SO injection and the 139 contralateral control (CL) eyes after a single normal saline injection once weekly for 8 weeks.
140 Surprisingly, IOP was lower in the SO eyes than in CL eyes when measured immediately after 141 anesthetizing the animals with isoflurane (Fig. 1C) . The TonoLab tonometer used to measure 142 mouse IOP is based on a rebound measuring principle that uses a very light weight probe to 143 make momentary contact with the center of the cornea, which primarily measures the pressure of eyes, if the diameter of the SO droplet was larger than 1.5mm ( Fig. 1D) . We achieved this size of 159 SO droplet in about 80% of mice, but in the 20% of mice with a small SO droplet (≤ 1.5mm) in 160 the anterior chamber due to poor injection or oil leaking, in which the IOP initially increased but 161 dropped soon afterwards ( Fig. 1D) . Therefore, by observing the size of the SO droplet, it is 162 possible to identify mice very early that will not show elevated IOP and exclude them from Because the mouse RNFL is too thin to be reliably measured, we used the thickness of GCC(36), 173 including RNFL, ganglion cell layer (GCL) and inner plexiform layer (IPL) together, to monitor 174 degeneration of RGC axons, somata, and dendrites caused by ocular hypertension. GCC in 175 SOHU eyes became gradually and progressively thinner (about 84%, 65%, 61% and 53% of CL 176 eyes) at 1, 3, 5 and 8 weeks post injection (wpi), although GCC thinning was not statistically 177 significant at 1wpi ( Fig. 2A,B) . These results indicate progressive RGC degeneration in response 178 to IOP elevation in SOHU eyes. OKR is a natural reflex that objectively assesses mouse visual acuity(37, 38). The mouse 195 eye will only track a grating stimulus that is moving from the temporal to nasal visual field, 196 which allows both eyes to be measured independently (38, 43) . It has been used to establish 197 correlations between visual deficit and RGC loss in the DBA/2 glaucoma mouse model(44). The 198 visual acuity of SOHU eyes decreased rapidly at 1wpi and stabilized for several more weeks 199 until 5wpi and 8wpi (Fig. 2C) . PERG is an important electrophysiological assessment of general 200 RGC function, in which the ERG responses are stimulated with contrast-reversing horizontal 201 bars alternating at constant mean luminance(39). Our PERG system measured both eyes at the 202 same time, so there was an internal control to use as a reference and normalization to minimize 203 the variations. Consistent with visual acuity deficit, the P1-N2 amplitude ratio of the SO eyes to 204 CL eyes decreased progressively (Fig. 2D,E) . These results suggest that RGCs are very sensitive 205 to IOP elevation, but resilient for a period of time before further degeneration. Taken together, 206 these in vivo results show that SOHU eyes developed progressive structural and visual function 207 deficits that closely resemble changes in glaucoma patients. SOHU and control eyes at 1wpi, whereas there was significant and worsening RGC loss at 3, 5 216 and 8wpi, when only 43%, 28%, and 12% of RGCs survived (Fig. 3A,B) . This result confirmed 217 significant progressive RGC death in response to IOP elevation in SOHU eyes. Significant RGC 218 axon degeneration also occured in SOHU eyes; only 57%, 41% and 35% RGC axons survived at 219 3, 5, and 8wpi ( Fig. 3A,C) . Therefore, IOP elevation in SOHU mouse eyes produces 220 glaucomatous RGC and ON degeneration that starts as early as 3wpi and becomes progressing 221 more severe at later time points that correlate with visual function deficits. Although the SO used in these studies was sterile and safe for human use, we considered 236 that toxicity might play a role in RGC death. Two experiments, however, provided evidence 237 against this possibility: First, SO intravitreal injection did not cause significant IOP elevation, 238 visual function deficits, or RGC/ON degeneration at 8wpi ( Fig. S1A-F) . Second, the eyes with 239 small SO droplets (≤ 1.5mm) and unstable IOP elevation ( Fig. 1D) showed no significant RGC 240 death or axon degeneration at 8wpi ( Fig. S1G,H) . Therefore, we conclude that the 246 We previously showed that ER stress is induced by ON injury and that CHOP deletion in 247 combination with XBP-1s overexpression synergistically promotes neuroprotection of RGC 248 somata and axons in mouse ON crush model, microbead-induced glaucoma model and 249 EAE/optic neuritis (29, 34, 35) . These results suggested that these ER stress molecules are 250 potential therapeutic targets for neuroprotection in optic neuropathies. We therefore examined 251 whether the SOHU model can be used to evaluate the effect of ER stress manipulation on 252 glaucomatous RGCs and ON. We previously demonstrated that the microRNA-based AAV-253 CHOP shRNA-GFP knocks down endogenous CHOP in mouse retinas and increases RGC soma 254 and axon survival in the ON crush model and microbeads-induced glaucoma model(29). We 255 modified this AAV vector by replacing GFP with XBP-1s to knockdown CHOP and express 256 XBP-1s with a single AAV vector. SO injection elevated IOP to a similar degree in mice injected 257 intravitreally with AAV-control shRNA-GFP or AAV-CHOP shRNA-XBP-1s (Fig. 4A) , but 258 significant differences in visual acuity and GCC thickness were present at 8wpi (Fig. 4B,C) . 259 About 60% of RGCs and 67% of axons survived at 8wpi in SOHU eyes injected with AAV-260 control shRNA-GFP, whereas approximately 91% of RGCs and 98% of axons survived in 261 SOHU eyes treated with AAV-CHOP shRNA-XBP-1s ( Fig. 4D,E) . We want to point out that 262 transduction of AAV itself produces noticeable neuroprotection compared to SOHU eyes 263 without AAV injection. Although the mechanism is unknown, AAV also provided 264 neuroprotection in other optic neuropathy models that we tested (data not shown). In summary, SOHU is a reversible ocular hypertension model 286 One of the disadvantages of many other glaucoma models is that the initial eye injury is 287 irreversible. However, we were able to flush out the SO from the anterior chamber with the aid 288 of normal saline infiltration (Fig. S2A, Movie S5) . This procedure lowered the IOP back to 289 normal quickly and stably ( Fig. S2B) A reliable animal glaucoma model that closely mimics the disease in humans is a prerequisite for 300 studies of pathogenetic mechanisms and for selecting efficient neuroprotective treatments for 301 clinical use. In the present study, we applied a highly effective and reproducible method adopted As in our previous studies of other optic neuropathy models (29, 34, 35) , we validated that 348 targeting CHOP and XBP-1 together provides significant neuroprotection in the SOHU model. 349 Moreover, we successfully used a single AAV vector to inhibit and activate different molecules injections, and may be applicable to a range of animal species with only minor modifications. 360 We also demonstrated that it is easily reversible by removing SO from the anterior chamber and 361 that is useful for screening neuroprotective therapies in vivo. Therefore we report this simple, isoflurane at 2 L/minute mixed with oxygen) delivered to the nose by a special rodent nose cone 411 (Xenotec, Inc., Rolla, Missouri), which left the eyes exposed for IOP measurement. The 412 TonoLab tonometer takes five measurements, eliminates high and low readings and generates an 413 average. We considered this machine-generated average as one reading. Three machine-414 generated readings were obtained from each eye, and the mean was calculated to determine the 415 IOP. During this procedure, artificial tears were applied to keep the cornea moist. The sine wave grating, consisting of black (mean luminance 0.22 cd/m2) and white (mean 461 luminance 152.13 cd/m2) at 100% contrast and 12 degree/second, provides a virtual-reality 462 environment to measure the spatial acuity of left eye when rotates clockwise and right eye when 463 it rotates counterclockwise. Initially, the monitors were covered with gray so that the mouse 464 calmed down and stopped moving, then the gray was switched to a low spatial frequency (0.1 465 cycle/degree) for five seconds, during which the mouse was assessed for whether the head turned 466 to track the grating. The short time frame of assessment ensures that the mice did not adapt to the 467 stimulus, which would lead to false readouts. When the mouse was determined to be capable of 468 tracking the grating, the spatial frequency was increased repeatedly until the maximum 469 frequency was identified and recorded. At each time point, the maximum frequency of the 470 experimental eye was compared to that of the contralateral eye. The mice were tested in the 471 morning and the investigator who judged the OKR was masked to the treatment of mice. 472 473 Statistical analyses. GraphPad Prism 6 was used to generate graphs and for statistical analyses. 474 Data are presented as means ± s.e.m. Student's t-test was used for two groups comparison and 475 One-way ANOVA with post hoc test was used for multiple comparisons. Peter H. Tang 1,3 , Vinit B. Mahajan 1,3 , Yang Sun 1,3 West Grove, Pennsylvania) and incubated for 1 hour at room temperature. Retinas were again 36 washed 3 times for 30 minutes each with PBS before a cover slip was attached with 37 Fluoromount-G (SouthernBiotech, Birmingham, Alabama). For RGC counting, whole-mount 38 retinas were immunostained with the RBPMS antibody, 6-9 fields randomly sampled from 39 peripheral regions of each retina using 40x lens with a Zeiss M2 epifluorescence microscope, 40 and RBPMS + RGCs counted by Volocity software (Quorum Technologies). The percentage of 41 RGC survival was calculated as the ratio of surviving RGC numbers in injured eyes compared to 42 contralateral uninjured eyes. The investigators who counted the cells were masked to the 43 treatment of the samples. 44 45 ON semi-thin sections and quantification of surviving axons. After mice were perfused 46 through the heart with ice cold 4% paraformaldehyde (PFA) in PBS, the ON was exposed by 47 removing the brain and post-fixed in situ using 2% glutaraldehyde/ 2% PFA in 0.1M PB for 4 48 hours on ice. Samples were then washed with 0.1M PB 3 times, 10 minutes each wash. The ONs 49 were then carefully dissected out and rinsed with 0.1M PB 3 times, 10 minutes each wash. They 50 were then incubated in 1% osmium tetroxide in 0.1M PB for 1 hour at room temperature 51 followed by washing with 0.1M PB for 10 minutes and water for 5 minutes. ONs were next 52 dehydrated through a series of graded ethanol (50% to 100%), rinsed twice with propylene oxide 53 (P.O.), 3 minutes each rinse, and transferred to medium containing 50% EMbed 812 / 50% P.O. 54 overnight. The next day, the medium was changed to a 2:1 ratio of EMbed 812/P.O. ONs 55 remained in this mixture overnight, then were transferred to 100% EMbed 812 on a rotator for 56 another 6 hours, embedded in a mold filled with 100% EMbed 812 and incubated at 60°C 57 overnight. Semi-thin sections (1 µm) were cut on an ultramicrotome (EM UC7, Leica, Wetzlar, 58 Germany) and collected 2 mm distal to the eye. The semi-thin sections were attached to glass 59 slides and stained with 1% para-phenylenediamine (PPD) in methanol: isopropanol (1:1) for 35 60 minutes. After rinsing 3 times with methanol: isopropanol (1:1), coverslips were applied with 61 Permount Mounting Medium (Electron Microscopy Sciences, Hatfield, Pennsylvania). PPD 62 stains all myelin sheaths, but darkly stains the axoplasm only of degenerating axons, which 63 allows us to differentiate surviving axons from degenerating axons(3). Four sections of each ON 64 were imaged through a 100x lens of a Zeiss M2 epifluorescence microscope to cover the entire 65 area of the ON without overlap. Two areas of 21.4 µm X 29.1 µm were cropped from the center 66 of each image, and the surviving axons within the designated areas were counted manually. After 67 counting all the images taken from a single nerve, the mean of the surviving axon number was 68 calculated for each ON. The mean of the surviving axon number in the injured ON was 69 compared to that in the contralateral control ON to yield a percentage of axon survival value. 70 The investigators who counted the axons were masked to the treatment of the samples. 
